Artivion AORT APAC — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's apac — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's APAC — total revenues?
- Artivion (AORT) reported APAC — total revenues of $8.69M in Q1 2026.
- How has Artivion's APAC — total revenues changed year-over-year?
- Artivion's APAC — total revenues increased by 5.8% year-over-year, from $8.21M to $8.69M.
- What is the long-term trend for Artivion's APAC — total revenues?
- Over 4 years (2021 to 2025), Artivion's APAC — total revenues has grown at a 19.5% compound annual growth rate (CAGR), from $21.7M to $44.25M.
- What does APAC — total revenues mean?
- This metric represents the total gross revenue generated by the company's operations within the Asia-Pacific geographic region. It reflects the market penetration and commercial success of the company's portfolio of cardiac and vascular surgical products in this specific territory. Monitoring this figure helps investors assess the company's international growth trajectory and the effectiveness of its regional sales and distribution strategies.